In 2002, the Flinn Foundation commissioned the creation of Arizona’s Bioscience Roadmap, the long-term strategic plan to advance Arizona’s bioscience sector. One of the four main strategies of the original Roadmap was to create a critical mass of bioscience firms in Arizona. In 2014, the Roadmap was updated, with the first of five new goals being to “Form a hub of bioscience entrepreneurs and new enterprises across Arizona.”
To address this goal, the Flinn Foundation Bioscience Entrepreneurship Program was established in 2013 to foster entrepreneurship and help early-stage bioscience firms develop into successful and sustainable businesses.
This competitive program provides $30,000 in funding support and a set of program services for up to six early-stage bioscience firms administered through a nonprofit partner. Opportunities are also offered to engage with the state’s bioscience, academic, and policy leaders.
To be eligible for the program, an entity must be a bioscience firm engaged in the commercialization of bioscience research and biotechnology and/or the sale of products in the areas of:
- Medical devices and equipment
- Drugs, pharmaceuticals and diagnostics
- Agricultural feedstock and chemicals
- Research, testing and medical labs
- Bioscience-related distribution
Over the past four years, the Flinn Foundation has selected 22 bioscience firms (see below) to participate in the program through a competitive process.
Learn more about the program by reading the 2017 Flinn Foundation Bioscience Entrepreneurship Brochure.
The 2018 application will be available later this year.
Flinn Foundation Bioscience Entrepreneurship Program Participants
Biosensing Instrument is a Tempe-based company that designs high-sensitivity instruments to analyze molecular interactions based on Surface Plasmon Resonance, a technique used across the life sciences and nanotechnology applications.
BMSEED, or BioMedical Sustainable Elastic Electronic Devices, is a Phoenix-based company that develops commercial products based on stretchable gold films. The company focuses on products for biomedical applications that require soft and stretchable electronic interfaces with cells, tissue, or skin.
Iron Horse Diagnostics, a Scottsdale-based company, is developing the first diagnostic test to rapidly determine if a patient has amyotrophic lateral sclerosis, or Lou Gehrig’s disease. The firm is also developing markers of disease progression to be used during clinical trials and a test to detect and monitor brain injury and concussion.
Phoenix Interface Technologies of Tempe has developed a solar-powered device that serves as a platform to attract and eliminate destructive disease-causing and crop-damaging insects. The device uses five sensory outputs to attract specific insects while sparing beneficial ones.
Poba Medical is a Flagstaff-based medical device company that provides engineering expertise in balloon design and development, device assembly, pilot manufacturing, and the production of catheter devices and intricate balloon assemblies.
Reglagene, a Tucson-based startup, uses a unique technology known as DNA quadruplex science to regulate genes as part of the drug-discovery process.
SMART Brain Aging is a Phoenix-based health-care technology company delivering research-supported programs, in person and virtually, that reduce cognitive decline in aging brains.
AniCell Biotech is a Chandler-based company that extends the active life of animals using a revolutionary treatment that can alleviate debilitating injuries through accelerated regeneration of tissue and bone. The treatment uses amnion growth factors and cellular components collected non-invasively during birth at zero risk to the animals.
bioSyntagma’s Light Stream FloCell is capable of extracting a single cell or bulk cells from a targeted area, facilitating the evolution of health care towards personalized medicine. The process developed by the Scottsdale-based company, formerly known as Omica Science, increases the overall quantity and quality of cellular material collected.
Breezing has created the world’s first mobile metabolism tracker that measures an individual’s metabolism through breathing. The Tempe-based company tracks one’s metabolism over time and integrates with weight, activity, and dieting goals to provide customized feedback on reaching weight goals.
EpiFinder’s proprietary app software enables neurologists to improve the consistency of seizure classification and the accuracy of epilepsy diagnosis. By providing quicker and more accurate diagnoses for a specific epilepsy syndrome, the Scottsdale-based EpiFinder reduces health-care costs for hospitals, enables doctors to provide personalized medicine, and helps to improve the quality of life of patients.
Neolight uses phototherapy beds to cure jaundice in pre-term and full-term babies quickly and without side effects. The Scottsdale-based company developed a small and portable incubator with LEDs that provides quick treatment time, reduces the amount of parts needed, uses a small amount of power, and enables newborns to remain close to their mothers.
Symple Surgical’s DirectAblate Renal Denervation System is designed to help hundreds of millions of patients worldwide living with chronic hypertension, or high blood pressure, through a minimally invasive vascular procedure. The system developed by the Flagstaff-based company delivers microwave thermal energy directly to the precise location of overactive sympathetic nerves while minimizing thermal exposure to non-targeted tissue.
EndoVantage is building a virtual patient treatment planning center in which medical procedures are planned before treatment and medical devices are tested before patient exposure, in both cases dramatically improving patient care and reducing cost. The EndoVantage Interventional Suite (EVIS) utilizes real patient data to plan patient-specific endovascular treatments and review the outcomes before surgery using advanced mathematics, computer modeling, and mechanical and fluid dynamics.
NextPotential recycles CO2 emissions directly into natural gas. NextPotential can produce natural gas for less than half the market price in the United States using the patented photocatalyst that is activated directly by light, with no additional thermal or photovoltaic energy input. The product is a modular, turnkey unit that can be easily integrated with existing infrastructure to generate a low-cost, zero-carbon biofuel that can be re-used onsite.
Photon Medical Communications has a secure communications software system that enables hospital emergency room physicians to share vital patient information with on-call specialists in “real-time” utilizing unique, patent-pending “push-notification” technology. Photon provides a HIPAA-compliant way for hospitals to relay images and lab results using mobile devices. Physicians can respond with directions using text or the voice transcription tool.
Pollen-Tech is developing a high-tech method to pollinate crops and reduce food growers’ dependence on standard bee pollination, which has become particularly important in light of the collapse of bee colonies around the world. The firm’s mission is to revolutionize agriculture by significantly improving food security in the United States and in countries around the world.
SiO2 Nanotech has created an anti-fogging technology that solves the problem of lens fogging for high-precision medical instrumentation. The company’s product controls droplet formation, and thus fogging, by physically changing the way the surface responds to condensation and ensuring the surface remains transparent. The technology has also established demand within the sports, automotive, construction, and consumer-goods industries.
Verve Medical is creating a medical device that uses radio frequency energy to stop certain nerves from causing high blood pressure. The technology is based on a non-surgical, non-invasive, low-risk, natural-orifice approach to Renal Denervation. The treatment is safe, bloodless and can be performed in an outpatient clinic or potentially an urologist’s office.
Arbsource designs, builds and sells electricity-producing, wastewater treatment equipment to breweries, dairies, potato chip companies, and similar customers, solving the problem of using old, inefficient, and expensive on-site treatment systems and incurring high raw wastewater discharge fees from municipalities.
MSDx is a diagnostics firm that provides novel biomarker tools for studying disease processes, including a blood test panel to monitor disease activity and therapeutic response to those individuals affected by Multiple Sclerosis and Parkinson’s Disease. These biomarkers may provide meaningful information that can aid in monitoring disease progression and response to drug therapy, predict an impending relapse, and facilitate drug development.
Pinnacle Transplant Technologies is a multi-service tissue bank that processes donated cadaveric tissues for transplant into live human recipients. The company has also developed and is commercializing a demineralized bone matrix (DBM) putty that is used with bone extending and grafting.